Source: International Congress 2019 – Clinical studies of asthma treatments
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
F. Cherubino (Tradate, Italy), G. Bertolotti (Tradate, Italy), A. Ianni (Tradate, Italy), A. De Lauretis (Garbagnate Milanese, Italy), R. Pintucci (Varese, Italy), D. Visca (Varese, Italy), E. Zampogna (Tradate, Italy), P. Pignatti (Pavia, Italy), A. Spanevello (Varese, Italy). Effects of Mepolizumab on symptoms, systemic and bronchial inflammation. 2550

Member's Comments

No comment yet.

Related content which might interest you: Effects of corticosteroids on airway inflammation in cough variant asthma Source: Annual Congress 2004 - Understanding airway regulation by airway monitoring Year: 2004 Effect of the addition of montelukast on airway inflammation and remodeling in symptomatic asthma Source: International Congress 2017 – Asthma: mechanisms and treatment Year: 2017 Anti-inflammatory effect of budesonide on the central and peripheral airway inflammation in cough-variant and mild bronchial asthma Source: Annual Congress 2008 - Comorbid cardiovascular condition and therapy of asthma Year: 2008 Effects of corticosteroid and montelukast treatment on distal lung parenchyma and airway walls in inflammation in guinea pigs with chronic allergic inflammation Source: Annual Congress 2011 - Experimental modulation of airway inflammation Year: 2011 Effect of previous physical conditioning on pulmonary inflammation and allergic immune response in a chronic allergic airway inflammation in mice Source: Eur Respir J 2007; 30: Suppl. 51, 370s Year: 2007 Effects of omalizumab on markers of eosinophilic inflammation in patients with severe allergic asthma Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011 Effect of treatment with anti-IgE antibody on airway inflammation in mild asthma Source: Eur Respir J 2003; 22: Suppl. 45, 203s Year: 2003 Oral tolerance attenuates airway remodelling in a model of chronic allergic inflammation Source: Eur Respir J 2006; 28: Suppl. 50, 591s Year: 2006 Effects of formoterol-budesonide combination on residual eosinophilic inflammation in distal airway of patients with well-controlled moderate asthma Source: Annual Congress 2011 - Asthma management and response Year: 2011 The effect of inhaled steroids on bronchial hyperreactivity, oxidative status, clinical and inflammatory paramerters in patients with cystic fibrosis Source: Annual Congress 2007 - Cystic fibrosis: the balance between treatment and side-effects Year: 2007 Systemic inflammation and endothelial dysfunction in patient with bronchial asthma Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD Year: 2008 Relationship between asthma and systemic inflammation Source: Annual Congress 2010 - Mechanisms and modulation of allergic inflammation in the lung Year: 2010 Importance of concomitant local and systemic eosinophilia in uncontrolled asthma Source: Eur Respir J 2014; 44: 1096-1098 Year: 2014 Importance of concomitant local and systemic eosinophilia in uncontrolled asthma Source: Eur Respir J 2014; 44: 97-108 Year: 2014 Importance of concomitant local and systemic eosinophilia in uncontrolled asthma Source: Eur Respir J 2014; 44: 1098-1099 Year: 2014 Effects of corticosteroid and montelukast treatment on distal lung parenchyma eosinophilic response in guinea pigs with chronic allergic inflammation Source: Annual Congress 2010 - Asthma: clinical aspects and treatment Year: 2010 Effects of corticosteroid and montelukast treatment in inflammation in guinea pigs with chronic allergic inflammation Source: Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD Year: 2012 Airway epithelial inflammatory responses and clinical parameters in COPD Source: Eur Respir J 2003; 22: 94-99 Year: 2003 IL-33 blockade impacts mediators of persistence and exacerbation of chronic airway inflammation. Source: International Congress 2018 – Novel drug targets for asthma and COPD Year: 2018 Effects of N-acetylcysteine on airway inflammation, airway hyperresponsiveness and abnormal lung function in chronic ozone-induced COPD model Source: Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD Year: 2012